AAP
KRMD icon

Arax Advisory Partners’s KORU Medical Systems KRMD Stock Holding History

Arax Advisory Partners’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45
Closed -$172 – 4320
2025
Q3 		$172 Buy
+45
New +$172 ﹤0.01% 3459

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $109M AUM
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arax Advisory Partners's KRMD Position: Q4 2025 in Review

Arax Advisory Partners sold out of KORU Medical Systems (KRMD) in Q4 2025, closing a stake of 45 shares — an estimated $172 sold.

Arax Advisory Partners first reported a position in KRMD in Q3 2025 and held it in 1 quarter. The position peaked at $172 in Q3 2025. 84 funds tracked by Wall St. Rank hold KRMD as of Q4 2025.

  • Arax Advisory Partners reported no remaining KORU Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 45 KORU Medical Systems shares in Q4 2025, an estimated $172.
  • Arax Advisory Partners first reported a position in KORU Medical Systems in Q3 2025 and held it in 1 quarter.
  • Arax Advisory Partners's KORU Medical Systems position peaked at $172 in Q3 2025.
  • 84 funds tracked by Wall St. Rank held KORU Medical Systems as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.